S8 Ep36: FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer
Apr 13, 2023
13:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Gilbert discusses the FDA approval of dostarlimab in patients with endometrial cancer, key efficacy data from the GARNET trial, and how this agent bolsters the endometrial cancer treatment paradigm.
OncLive® On Air